Fanconi Anemia Complementation Group D2 Protein

Known as: Fanconi Anemia Complementation Group D2 Protein [Chemical/Ingredient], FANCD2, Fanconi Anemia Group D2 Complementing Protein 
A Fanconi anemia complementation group protein that undergoes mono-ubiquitination by FANCL PROTEIN in response to DNA DAMAGE. Also, in response to… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2001-2017
0102020012017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Several inherited syndromes in humans are associated with cancer predisposition. The gene products defective in two of these… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Activation of the Fanconi anemia (FA) DNA damage–response pathway results in the monoubiquitination of FANCD2, which is regulated… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Fanconi anemia (FA) is a developmental and cancer-predisposition syndrome caused by mutations in genes controlling DNA… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Fanconi anemia is a genetic disease characterized by genomic instability and cancer predisposition. Nine genes involved in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Protein ubiquitination and deubiquitination are dynamic processes implicated in the regulation of numerous cellular pathways… (More)
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Fanconi anemia is a recessively inherited disease characterized by congenital defects, bone marrow failure and cancer… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Ovarian tumor cells are often genomically unstable and hypersensitive to cisplatin. To understand the molecular basis for this… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Fanconi anemia (FA) is a human autosomal recessive cancer susceptibility disorder characterized by cellular sensitivity to… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Fanconi anemia (FA) and ataxia telangiectasia (AT) are clinically distinct autosomal recessive disorders characterized by… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Fanconi anemia (FA) is a genetic disease with birth defects, bone marrow failure, and cancer susceptibility. To date, genes for… (More)
Is this relevant?